Could metformin be a game changer for heart health in non-diabetics?

Using Mendelian randomization, researchers found that altering seven metformin targets led to improved blood pressure and BMI in non-diabetic individuals. The study suggests the potential for metformin’s role in reducing cardiovascular risks in the general population, although more research is needed.

BT-7480 by Bicycle Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

November 18, 2023

Immunovant shares mid-stage Graves’ disease data; FDA lifts Rezolute’s hold

Plus, news about Xencor, Bambusa Therapeutics, Grin Therapeutics and Vaxcyte: Immunovant reports Phase 2a Graves’ disease data: Patients taking batoclimab for 12 weeks saw a

September 10, 2024

Study links high sugar intake to lower childhood asthma risk, while fat, magnesium, and vitamin D increase it

Using Mendelian Randomization, researchers found that high sugar intake may lower childhood asthma risk, while high fat, magnesium, and vitamin D intake increase it.

May 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.